title: Selected heterocyclic amines.
mesh_terms: D000588:Amines / Q000737:chemistry / Q000494:pharmacology / Q000633:toxicity*; D000818:Animals; D000831:Animals, Newborn; D015197:Carcinogenicity Tests; D002273:Carcinogens / Q000737:chemistry / Q000494:pharmacology / Q000633:toxicity*; D002478:Cells, Cultured; D004781:Environmental Exposure / Q000009:adverse effects / Q000331:legislation & jurisprudence; D005260:Female; D033161:Government Regulation; D017408:Guidelines as Topic; D006571:Heterocyclic Compounds / Q000737:chemistry / Q000494:pharmacology / Q000633:toxicity*; D006801:Humans; D007093:Imidazoles / Q000737:chemistry / Q000494:pharmacology / Q000633:toxicity; D008252:Macaca fascicularis; D008297:Male; D051379:Mice; D008954:Models, Biological; D011804:Quinolines / Q000737:chemistry / Q000494:pharmacology / Q000633:toxicity; D011810:Quinoxalines / Q000737:chemistry / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D014481:United States
chemical_list: D000588:Amines; D002273:Carcinogens; D006571:Heterocyclic Compounds; D007093:Imidazoles; D011804:Quinolines; D011810:Quinoxalines; C029216:2-amino-3-methylimidazo(4,5-f)quinoline; C036990:2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline; C049584:2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine; C036989:2-amino-3,4-dimethylimidazo(4,5-f)quinoline